Stay updated on IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page.

Latest updates to the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page
- Check7 days agoChange DetectedThe page’s revision label in the footer was updated from v3.6.4 to v3.6.5, signaling a minor platform update rather than a change to the study data list. This update affects how the page presents its version, not the content of the record history.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing v3.6.3. This appears to be a metadata update rather than a user-facing content change.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedThe record history now shows a new revision label v3.6.3, replacing the previous v3.6.2. This indicates a backend/UI update to how the history is presented for this study page.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page’s revision label was updated to v3.6.2, replacing the previous v3.6.0, indicating a platform version update reflected in the history view rather than a modification to the study data.SummaryDifference0.1%

- Check64 days agoChange DetectedRecruitment status updated to not looking for participants. The record shows a new revision (v3.6.0) and the prior revision (v3.5.5) was removed.SummaryDifference0.2%

- Check71 days agoChange DetectedNew revision label v3.5.5 was added to the record history, replacing the previous v3.5.4. This indicates an update to the page's versioning information.SummaryDifference0.1%

Stay in the know with updates to IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page.